Chase Science Co., Ltd

SZSE:300941 Stock Report

Market Cap: CN¥2.7b

Chase Science Balance Sheet Health

Financial Health criteria checks 6/6

Chase Science has a total shareholder equity of CN¥1.3B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.4B and CN¥89.9M respectively. Chase Science's EBIT is CN¥14.0M making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥788.3M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-0.7x
CashCN¥788.28m
EquityCN¥1.32b
Total liabilitiesCN¥89.88m
Total assetsCN¥1.41b

Recent financial health updates

No updates

Recent updates

Analysis Article Jan 24

Chase Science's (SZSE:300941) Returns On Capital Not Reflecting Well On The Business

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Analysis Article Dec 26

Chase Science Co., Ltd's (SZSE:300941) 39% Share Price Surge Not Quite Adding Up

Despite an already strong run, Chase Science Co., Ltd ( SZSE:300941 ) shares have been powering on, with a gain of 39...
Analysis Article Nov 05

Chase Science's (SZSE:300941) Weak Earnings May Only Reveal A Part Of The Whole Picture

The market wasn't impressed with the soft earnings from Chase Science Co., Ltd ( SZSE:300941 ) recently. Our analysis...
Analysis Article Sep 30

Chase Science Co., Ltd (SZSE:300941) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Chase Science Co., Ltd ( SZSE:300941 ) shares have had a really impressive month, gaining 41% after a shaky period...
Analysis Article Jun 17

Chase Science's (SZSE:300941) Shareholders Will Receive A Smaller Dividend Than Last Year

Chase Science Co., Ltd ( SZSE:300941 ) is reducing its dividend from last year's comparable payment to CN¥0.14 on the...
Analysis Article Jun 08

Investors Could Be Concerned With Chase Science's (SZSE:300941) Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Analysis Article Apr 21

More Unpleasant Surprises Could Be In Store For Chase Science Co., Ltd's (SZSE:300941) Shares After Tumbling 25%

Unfortunately for some shareholders, the Chase Science Co., Ltd ( SZSE:300941 ) share price has dived 25% in the last...
Analysis Article Mar 04

What Chase Science Co., Ltd's (SZSE:300941) 26% Share Price Gain Is Not Telling You

Chase Science Co., Ltd ( SZSE:300941 ) shareholders are no doubt pleased to see that the share price has bounced 26% in...
Analysis Article Feb 27

Returns On Capital Signal Tricky Times Ahead For Chase Science (SZSE:300941)

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Financial Position Analysis

Short Term Liabilities: 300941's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥81.4M).

Long Term Liabilities: 300941's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥8.5M).


Debt to Equity History and Analysis

Debt Level: 300941 is debt free.

Reducing Debt: 300941 had no debt 5 years ago.

Debt Coverage: 300941 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 300941 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/08 11:28
End of Day Share Price 2026/07/08 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Chase Science Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.